BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 25548835)

  • 1. Use of allogeneic stem cell transplantation for moderate-severe Glanzmann thrombasthenia.
    Walz A; Lenzen A; Curtis B; Canner J; Schneiderman J
    Platelets; 2015; 26(7):702-4. PubMed ID: 25548835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic hematopoietic stem cell transplantation in Glanzmann thrombasthenia complicated by platelet alloimmunization.
    Wiegering V; Winkler B; Langhammer F; Wölfl M; Wirbelauer J; Sauer K; Kobsar A; Meyer T; Strauss A; Bakchoul T; Eyrich M; Schlegel PG
    Klin Padiatr; 2011 May; 223(3):173-5. PubMed ID: 21567370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic stem cell transplantation for Glanzmann thrombasthenia.
    Ishaqi MK; El-Hayek M; Gassas A; Khanani M; Trad O; Baroudi M; Jamil A
    Pediatr Blood Cancer; 2009 May; 52(5):682-3. PubMed ID: 19101997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained engraftment and resolution of bleeding phenotype after unrelated cord blood hematopoietic stem cell transplantation for severe glanzmann thrombasthenia.
    Miller W; Dunn A; Chiang KY
    J Pediatr Hematol Oncol; 2009 Jun; 31(6):437-9. PubMed ID: 19648793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem Cell Transplant in Severe Glanzmann Thrombasthenia in an Adult Patient.
    Ramzi M; Dehghani M; Haghighat S; Nejad HH
    Exp Clin Transplant; 2016 Dec; 14(6):688-690. PubMed ID: 26134714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow transplantation in severe Glanzmann's thrombasthenia with antiplatelet alloimmunization.
    Bellucci S; Damaj G; Boval B; Rocha V; Devergie A; Yacoub-Agha I; Garderet L; Ribaud P; Traineau R; Socié G; Gluckman E
    Bone Marrow Transplant; 2000 Feb; 25(3):327-30. PubMed ID: 10673707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Insights Into the Treatment of Glanzmann Thrombasthenia.
    Poon MC; Di Minno G; d'Oiron R; Zotz R
    Transfus Med Rev; 2016 Apr; 30(2):92-9. PubMed ID: 26968829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained engraftment post bone marrow transplant despite anti-platelet antibodies in Glanzmann thrombasthenia.
    Flood VH; Johnson FL; Boshkov LK; Thomas GA; Nugent DJ; Bakke AC; Nicholson HS; Tilford D; Brown MP; Godder KT
    Pediatr Blood Cancer; 2005 Dec; 45(7):971-5. PubMed ID: 15768382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell transplantation for children with Glanzmann thrombasthenia.
    Connor P; Khair K; Liesner R; Amrolia P; Veys P; Ancliff P; Mathias M
    Br J Haematol; 2008 Mar; 140(5):568-71. PubMed ID: 18205861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indication for allogeneic stem cell transplantation in Glanzmann's thrombasthenia.
    Wiegering V; Sauer K; Winkler B; Eyrich M; Schlegel PG
    Hamostaseologie; 2013; 33(4):305-12. PubMed ID: 23868573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glanzmann thrombasthenia: an update.
    Franchini M; Favaloro EJ; Lippi G
    Clin Chim Acta; 2010 Jan; 411(1-2):1-6. PubMed ID: 19854165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful unrelated donor cord blood transplantation for Glanzmann's thrombasthenia.
    Kitko CL; Levine JE; Matthews DC; Carpenter PA
    Pediatr Transplant; 2011 May; 15(3):e42-6. PubMed ID: 19849809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification of Iranian patients with Glanzmann's Thrombasthenia using a flow cytometric method.
    Farsinejad A; Abolghasemi H; Kazemi A; Aghaiipour M; Hadjati E; Faranoush M; Jazebi M; Ala F
    Platelets; 2011; 22(5):321-7. PubMed ID: 21526886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glanzmann thrombasthenia: state of the art and future directions.
    Nurden AT; Pillois X; Wilcox DA
    Semin Thromb Hemost; 2013 Sep; 39(6):642-55. PubMed ID: 23929305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should HLA and HPA-matched platelet transfusions for patients with Glanzmann Thrombasthenia or Bernard-Soulier syndrome be standardized care? A Dutch survey and recommendations.
    Huisman EJ; Holle N; Schipperus M; Cnossen MH; de Haas M; Porcelijn L; Zwaginga JJ
    Transfusion; 2024 May; 64(5):824-838. PubMed ID: 38642032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rare case of bleeding disorder: Glanzmann's thrombasthenia.
    Swathi J; Gowrishankar A; Jayakumar SA; Jain K
    Ann Afr Med; 2017; 16(4):196-198. PubMed ID: 29063905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem-cell transplantation in children with acute lymphoblastic leukemia: A prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trial.
    Peters C; Schrappe M; von Stackelberg A; Schrauder A; Bader P; Ebell W; Lang P; Sykora KW; Schrum J; Kremens B; Ehlert K; Albert MH; Meisel R; Matthes-Martin S; Gungor T; Holter W; Strahm B; Gruhn B; Schulz A; Woessmann W; Poetschger U; Zimmermann M; Klingebiel T
    J Clin Oncol; 2015 Apr; 33(11):1265-74. PubMed ID: 25753432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glanzmann thrombasthenia.
    Nurden AT
    Orphanet J Rare Dis; 2006 Apr; 1():10. PubMed ID: 16722529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet gene therapy improves hemostatic function for integrin alphaIIbbeta3-deficient dogs.
    Fang J; Jensen ES; Boudreaux MK; Du LM; Hawkins TB; Koukouritaki SB; Cornetta K; Wilcox DA
    Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9583-8. PubMed ID: 21606353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency.
    Al-Mousa H; Al-Shammari Z; Al-Ghonaium A; Al-Dhekri H; Al-Muhsen S; Al-Saud B; Arnaout R; Al-Seraihy A; Al-Jefri A; Al-Ahmari A; Ayas M; El-Solh H
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):818-23. PubMed ID: 20079864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.